Eight years later, Bristol-Myers acquired Mead Johnson & Company, which was a leader in science-based infant and children's nutrition. Squibb, on the other hand, delved into cancer research ...

Phoenix Children's, one of the nation's fastest-growing pediatric healthcare systems, appointed a new division chief to lead the vital area of pediatric ...

If you’re under age 12, we don’t have any drug that is specifically indicated,” Dr. Lawrence F. Eichenfield said.

The Burnout Prevention Program® now features gamification tools that transform learning into an engaging and rewarding journey. Healthcare professionals can earn badges, track progress in real-time, ...

To get a sense of who is truly in control of Bristol-Myers Squibb Company (NYSE:BMY), it is important to understand the ownership structure of the business. And the group that holds the biggest ...

Whales with a lot of money to spend have taken a noticeably bearish stance on Bristol-Myers Squibb. Looking at options history for Bristol-Myers Squibb BMY we detected 26 trades. If we consider ...

In this article, we are going to take a look at where Bristol-Myers Squibb Company (NYSE:BMY) stands against the other dividend stocks. Dividend stocks, while popular among investors, have been ...

The new product will help Bristol Myers Squibb compete with biosimilars as Opdivo faces looming patent expiration. Sotyktu, which became the first TYK2 inhibitor to reach the market after its 2022 ...

In this article, we are going to take a look at where Bristol-Myers Squibb Company (NYSE:BMY) stands against the other high-yield dividend stocks. Dividend stocks have been investors’ favorites ...